These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18240505)

  • 21. A risk-based approach to scheduling audits.
    Rönninger S; Holmes M
    PDA J Pharm Sci Technol; 2009; 63(6):575-88. PubMed ID: 20169864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experiences with GCP in the pharmaceutical industry [corrected].
    Rämsch KD
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):237-40. PubMed ID: 8240533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent changes in quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Fujimura A
    Ann Pharmacother; 2004 Jan; 38(1):151-5. PubMed ID: 14742810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [International standards concerned with total quality control].
    Jedra M
    Rocz Panstw Zakl Hig; 1993; 44(2-3):133-8. PubMed ID: 8016533
    [No Abstract]   [Full Text] [Related]  

  • 26. [Quality management program for contract physicians. In an unbelievably short time a superior new concept is developed].
    Diel F
    MMW Fortschr Med; 2005 May; 147(20):14. PubMed ID: 15957853
    [No Abstract]   [Full Text] [Related]  

  • 27. Setting new standards.
    Nat Rev Drug Discov; 2005 Nov; 4(11):869. PubMed ID: 16299911
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and quality in clinical trials. Requirements to the investigator site. European Economic Community.
    Friederichs E; Spitzer SG; Bach R
    Arzneimittelforschung; 1994 Feb; 44(2):182-4. PubMed ID: 8147953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of total quality principles to achieve regulatory compliance in research laboratories.
    Hynes MD
    Qual Assur; 1995 Mar; 4(1):34-40. PubMed ID: 8520863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ISO standards. Measuring up to the world.
    Dunmire TD
    Occup Health Saf; 2002 Sep; 71(9):233-6. PubMed ID: 12369372
    [No Abstract]   [Full Text] [Related]  

  • 31. True, false, whatever.
    Schultz S
    US News World Rep; 2001 Sep; 131(10):72-3. PubMed ID: 11573469
    [No Abstract]   [Full Text] [Related]  

  • 32. The industrialization of clinical research.
    Rettig RA
    Health Aff (Millwood); 2000; 19(2):129-46. PubMed ID: 10718027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of standards for quality management in interventional cardiology].
    Brennecke R
    Herz; 1996 Oct; 21(5):304-13. PubMed ID: 9011539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical drive prompts pharma and academia to partner up.
    Scudellari M
    Nat Med; 2011 Jan; 17(1):3. PubMed ID: 21217649
    [No Abstract]   [Full Text] [Related]  

  • 35. Institutional mistrust in the organization of pharmaceutical clinical trials.
    Fisher JA
    Med Health Care Philos; 2008 Dec; 11(4):403-13. PubMed ID: 18633728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL; Lynch MA
    J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802
    [No Abstract]   [Full Text] [Related]  

  • 37. How to ensure supplier quality from your supplier management program.
    Weiss MS
    Hosp Mater Manage Q; 1998 Feb; 19(3):1-10. PubMed ID: 10176280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of highly specialized clinical drug trial units within health care institutions].
    Stanimirović V; Babić M; Nikolić D; Cucak S; Nikolić A
    Srp Arh Celok Lek; 2000; 128(7-8):253-8. PubMed ID: 11089432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint.
    Legler UF
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.